G M Asnis

Summary

Publications

  1. doi request reprint Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study
    Gregory M Asnis
    Albert Einstein College of Medicine, Montefiore Medical Center, 111 East 210th St, Bronx, NY 10467
    J Clin Psychiatry 74:242-8. 2013
  2. ncbi request reprint Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients
    G M Asnis
    Department of Psychiatry, Albert Einstein College of Medicine, Montefiore Medical Center, 111 E 210th Street, Bronx, New York, NY 10467 2490, USA
    Psychiatry Res 103:1-14. 2001
  3. ncbi request reprint Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches
    Gregory M Asnis
    Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Montefiore Medical Center, Anxiety and Depression Program, Klau Basement, 111 E 210th Street, Bronx, New York 10467, USA
    J Clin Gastroenterol 40:322-35. 2006
  4. ncbi request reprint IFN-induced depression: a role for NSAIDs
    Gregory M Asnis
    Department of Internal Medicine, Yeshiva University s Albert Einstein College of Medicine, and Anxiety and Depression Program, Montifiore Medical Center, Bronx, NY, USA
    Psychopharmacol Bull 37:29-50. 2003
  5. ncbi request reprint Interferon-induced depression: strategies in treatment
    Gregory M Asnis
    Albert Einstein College of Medicine, Montefiore Medical Center, Anxiety and Depression Program, 111 E 210th Street, Bronx, NY, USA
    Prog Neuropsychopharmacol Biol Psychiatry 29:808-18. 2005
  6. ncbi request reprint SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations
    Gregory M Asnis
    Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10467, USA
    Drugs 64:383-404. 2004
  7. ncbi request reprint Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C
    C L Raison
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
    Aliment Pharmacol Ther 25:1163-74. 2007
  8. ncbi request reprint Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial
    K Brady
    Department of Psychiatry, Medical University of South Carolina, Charleston 29425, USA
    JAMA 283:1837-44. 2000
  9. ncbi request reprint Ribavirin may be an important factor in IFN-induced neuropsychiatric effects
    Gregory M Asnis
    J Clin Psychiatry 65:581; author reply 581-2. 2004
  10. ncbi request reprint Combined antidepressant treatment: a risk factor for switching in bipolar patients
    Vilma Gabbay
    J Clin Psychiatry 63:367; author reply 367-8. 2002

Collaborators

Detail Information

Publications20

  1. doi request reprint Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study
    Gregory M Asnis
    Albert Einstein College of Medicine, Montefiore Medical Center, 111 East 210th St, Bronx, NY 10467
    J Clin Psychiatry 74:242-8. 2013
    ....
  2. ncbi request reprint Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients
    G M Asnis
    Department of Psychiatry, Albert Einstein College of Medicine, Montefiore Medical Center, 111 E 210th Street, Bronx, New York, NY 10467 2490, USA
    Psychiatry Res 103:1-14. 2001
    ..Significant improvement was evident as early as week 1 for some panic variables. Fluvoxamine is a potent anti-panic agent with a relatively rapid onset of action...
  3. ncbi request reprint Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches
    Gregory M Asnis
    Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Montefiore Medical Center, Anxiety and Depression Program, Klau Basement, 111 E 210th Street, Bronx, New York 10467, USA
    J Clin Gastroenterol 40:322-35. 2006
    ..Finally, a discussion is provided on the use of antidepressants as a preventative versus restorative treatment, including a commentary on risks of using antidepressants in this patient population...
  4. ncbi request reprint IFN-induced depression: a role for NSAIDs
    Gregory M Asnis
    Department of Internal Medicine, Yeshiva University s Albert Einstein College of Medicine, and Anxiety and Depression Program, Montifiore Medical Center, Bronx, NY, USA
    Psychopharmacol Bull 37:29-50. 2003
    ....
  5. ncbi request reprint Interferon-induced depression: strategies in treatment
    Gregory M Asnis
    Albert Einstein College of Medicine, Montefiore Medical Center, Anxiety and Depression Program, 111 E 210th Street, Bronx, NY, USA
    Prog Neuropsychopharmacol Biol Psychiatry 29:808-18. 2005
    ..On the basis of known and effective treatment strategies, IFN-induced depression should not be an obstacle for continued treatment in most patient populations...
  6. ncbi request reprint SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations
    Gregory M Asnis
    Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10467, USA
    Drugs 64:383-404. 2004
    ....
  7. ncbi request reprint Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C
    C L Raison
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
    Aliment Pharmacol Ther 25:1163-74. 2007
    ..Whether antidepressants prevent depression during interferon-alpha/ribavirin treatment for hepatitis C virus infection has yet to be established...
  8. ncbi request reprint Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial
    K Brady
    Department of Psychiatry, Medical University of South Carolina, Charleston 29425, USA
    JAMA 283:1837-44. 2000
    ..Despite the high prevalence, chronicity, and associated comorbidity of posttraumatic stress disorder (PTSD) in the community, few placebo-controlled studies have evaluated the efficacy of pharmacotherapy for this disorder...
  9. ncbi request reprint Ribavirin may be an important factor in IFN-induced neuropsychiatric effects
    Gregory M Asnis
    J Clin Psychiatry 65:581; author reply 581-2. 2004
  10. ncbi request reprint Combined antidepressant treatment: a risk factor for switching in bipolar patients
    Vilma Gabbay
    J Clin Psychiatry 63:367; author reply 367-8. 2002
  11. ncbi request reprint Recombinant human interferon-alpha does not alter reward behavior, or neuroimmune and neuroendocrine activation in rats
    Richard De La Garza
    Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, 740 Westwood Boulevard, NPI A8 148, Los Angeles, CA 90024, USA
    Prog Neuropsychopharmacol Biol Psychiatry 29:781-92. 2005
    ..Despite the neurochemical alterations observed in the chronic treatment regimen, the data indicate that recombinant human IFN-alpha does not produce a robust model of depressive-like behavior in rodents...
  12. ncbi request reprint Interferon for hepatitis C patients with psychiatric disorders
    Gregory M Asnis
    Am J Psychiatry 161:2332; author reply 2332-4. 2004
  13. ncbi request reprint Neuropsychiatric impact of hepatitis C on advanced HIV
    Gregory M Asnis
    Neurology 64:768; author reply 768. 2005
  14. ncbi request reprint The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release
    Richard De La Garza
    Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Forchheimer Building, Room 111, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Behav Brain Res 149:77-85. 2004
    ....
  15. ncbi request reprint Safety and tolerability of lamotrigine for bipolar disorder
    Charles L Bowden
    Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229 3900, USA
    Drug Saf 27:173-84. 2004
    ..These findings - considered in the context of data showing lamotrigine to be effective for bipolar depression - establish lamotrigine as a well-tolerated addition to the psychotropic armamentarium...
  16. ncbi request reprint Increased personality disorders and Axis I comorbidity in atypical depression
    Lata K McGinn
    Ferkauf Graduate School of Psychology, Yeshiva University, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Compr Psychiatry 46:428-32. 2005
    ..Comparison of patients with and without atypical depression on comorbid Axis I and I disorders to determine whether atypical depression is associated with a higher comorbidity...
  17. ncbi request reprint The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus
    Richard De La Garza
    Albert Einstein College of Medicine, Department of Psychiatry and Behavioral Sciences, Forchheimer, Room 111, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Brain Res 977:70-9. 2003
    ..These data offer support for a novel role of NSAIDs in modulating IFN-alpha-induced neurochemical alterations, and raise the possibility of the use of NSAIDs for the prevention of IFN-alpha-induced depression...
  18. ncbi request reprint Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management
    Michael J Maher
    Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10467, USA
    CNS Drugs 20:567-90. 2006
    ..Controlled studies are needed to confirm these promising findings...
  19. ncbi request reprint Effect of lamotrigine on cognitive complaints in patients with bipolar I disorder
    Arifulla Khan
    Northwest Clinical Research Center, Bellevue, Wash 98004, USA
    J Clin Psychiatry 65:1483-90. 2004
    ..This analysis describes the effects of bipolar I disorder on self-reported neurocognitive measures and remediation of these deficits with lamotrigine therapy...
  20. ncbi request reprint Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats
    Richard De La Garza
    Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Forchheimer Building, Room 111, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Psychopharmacology (Berl) 179:356-65. 2005
    ....